Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|March 1, 2006
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosisAmir Sharabi, Asher Haviv, Heidy Zinger, et al.Journal of Neuroimmunology|December 7, 2010
Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestationsAlona Telerman, Smadar Lapter, Amir Sharabi, et al.Immunology|December 2, 2008
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine modelsUri Sela, Amir Sharabi, Molly Dayan, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretionUri Sela, Rami Hershkoviz, Liora Cahalon, et al.Plos One|April 5, 2013
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosusZev Sthoeger, Heidy Zinger, Amir Sharabi, et al.Clinical Immunology (Orlando, Fla.)|September 1, 2018
Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1Zev Sthoeger, Amir Sharabi, Heidy Zinger, et al.Journal of Clinical Immunology|December 29, 2004
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulationDror Luger, Molly Dayan, Heidy Zinger, et al.Plos One|December 31, 2009
In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in miceArnon Arazi, Amir Sharabi, Heidy Zinger, et al.Clinical Immunology (Orlando, Fla.)|February 4, 2009
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupusReshmi Parameswaran, Hava Ben David, Amir Sharabi, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 2006
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-betaAmir Sharabi, Heidy Zinger, Maya Zborowsky, et al.Pageof 9